Beijing Minhai Biotechnology Co., Ltd
10 clinical trials · Sponsor
◉ Watch Beijing Minhai Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine (NCT06608199) | Beijing Minhai Biotechnology Co., Ltd | 2024-11-01 |
| Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine (NCT07740733) | Beijing Minhai Biotechnology Co., Ltd | 2024-02-29 |
| A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants (NCT06752174) | Beijing Minhai Biotechnology Co., Ltd | 2023-03-08 |
| A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) (NCT04756323) | Beijing Minhai Biotechnology Co., Ltd | 2020-10-27 |
| A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years (NCT06210737) | Beijing Minhai Biotechnology Co., Ltd | 2019-09-26 |
Track Beijing Minhai Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.